Clinical Lung Cancer

Edit Your Profile

Clinical Lung Cancer Journal

publication venue for

The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer. 23:52-59. 2022
EGFR L718V (+)/T790M (-) as a Mechanism of Resistance in Patients with Metastatic Non-small-cell Lung Cancer with EGFR L858R Mutations. 22:E817-E819. 2021
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America. 18:E71-E79. 2017
Strategies to Prevent Brain Metastasis in High-Risk Non-Small-Cell Lung Cancer: Lessons Learned From a Randomized Study of Maintenance Temozolomide Versus Observation. 15:433-440. 2014
Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer. 7:107-113. 2005
Megavoltage computed tomography imaging: A potential tool to guide and improve the delivery of thoracic radiation therapy. 5:303-306. 2004
Pilot and safety trial of carboplatin, paclitaxel, and thalidomide in advanced non-small-cell lung cancer. 2:48-52. 2000
Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients 2015
Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer 2010
Gene expression profiling and non-small-cell lung cancer: Where are we now? 2009
Second-line therapy for non-small-cell lung cancer 2009
Gender issues and the molecular epidemiology of lung cancer risk. 2008

International Standard Serial Number (ISSN)

1525-7304

Electronic International Standard Serial Number (EISSN)

1938-0690